Search research articles
Contact Us
Filters
Showing results (71-80 of 86) with videos related to
Page
of 9
Sort By:
Journal for Immunotherapy of Cancer
|
March 18, 2025
Progesterone receptor-dependent downregulation of MHC class I promotes tumor immune evasion and growth in breast cancer
Julio C Tinoco, Harmony I Saunders, Lauryn Rose Werner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 6, 2019
MYC-Driven Small-Cell Lung Cancer is Metabolically Distinct and Vulnerable to Arginine Depletion
Milind D Chalishazar, Sarah J Wait, Fang Huang, et al.
Cancer Cell
|
June 1, 2020
MYC Drives Temporal Evolution of Small Cell Lung Cancer Subtypes by Reprogramming Neuroendocrine Fate
Abbie S Ireland, Alexi M Micinski, David W Kastner, et al.
Immunity
|
October 18, 2018
The Lineage-Defining Transcription Factors SOX2 and NKX2-1 Determine Lung Cancer Cell Fate and Shape the Tumor Immune Microenvironment
Gurkan Mollaoglu, Alex Jones, Sarah J Wait, et al.
Genome Medicine
|
July 30, 2017
Post-mortem molecular profiling of three psychiatric disorders
Ryne C Ramaker, Kevin M Bowling, Brittany N Lasseigne, et al.
Nature Communications
|
April 20, 2022
ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation
Zheqi Li, Olivia McGinn, Yang Wu, et al.
Oncotarget
|
December 29, 2016
Genomic regulation of invasion by STAT3 in triple negative breast cancer
Joy M McDaniel, Katherine E Varley, Jason Gertz, et al.
Cancer Research
|
January 23, 2016
Discordant Haplotype Sequencing Identifies Functional Variants at the 2q33 Breast Cancer Risk Locus
Nicola J Camp, Wei-Yu Lin, Alex Bigelow, et al.
Blood
|
November 15, 2021
MS4A3 promotes differentiation in chronic myeloid leukemia by enhancing common β-chain cytokine receptor endocytosis
Helong Zhao, Anthony D Pomicter, Anna M Eiring, et al.
Cancer Cell
|
January 17, 2017
MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition
Gurkan Mollaoglu, Matthew R Guthrie, Stefanie Böhm, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 86) with videos related to
Sort By:
Page
of 9
Journal for Immunotherapy of Cancer
|
March 18, 2025
Progesterone receptor-dependent downregulation of MHC class I promotes tumor immune evasion and growth in breast cancer
Julio C Tinoco, Harmony I Saunders, Lauryn Rose Werner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 6, 2019
MYC-Driven Small-Cell Lung Cancer is Metabolically Distinct and Vulnerable to Arginine Depletion
Milind D Chalishazar, Sarah J Wait, Fang Huang, et al.
Cancer Cell
|
June 1, 2020
MYC Drives Temporal Evolution of Small Cell Lung Cancer Subtypes by Reprogramming Neuroendocrine Fate
Abbie S Ireland, Alexi M Micinski, David W Kastner, et al.
Immunity
|
October 18, 2018
The Lineage-Defining Transcription Factors SOX2 and NKX2-1 Determine Lung Cancer Cell Fate and Shape the Tumor Immune Microenvironment
Gurkan Mollaoglu, Alex Jones, Sarah J Wait, et al.
Genome Medicine
|
July 30, 2017
Post-mortem molecular profiling of three psychiatric disorders
Ryne C Ramaker, Kevin M Bowling, Brittany N Lasseigne, et al.
Nature Communications
|
April 20, 2022
ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation
Zheqi Li, Olivia McGinn, Yang Wu, et al.
Oncotarget
|
December 29, 2016
Genomic regulation of invasion by STAT3 in triple negative breast cancer
Joy M McDaniel, Katherine E Varley, Jason Gertz, et al.
Cancer Research
|
January 23, 2016
Discordant Haplotype Sequencing Identifies Functional Variants at the 2q33 Breast Cancer Risk Locus
Nicola J Camp, Wei-Yu Lin, Alex Bigelow, et al.
Blood
|
November 15, 2021
MS4A3 promotes differentiation in chronic myeloid leukemia by enhancing common β-chain cytokine receptor endocytosis
Helong Zhao, Anthony D Pomicter, Anna M Eiring, et al.
Cancer Cell
|
January 17, 2017
MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition
Gurkan Mollaoglu, Matthew R Guthrie, Stefanie Böhm, et al.
Page
of 9